| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |